IDiyas

For the Inventor, By the Inventor

Pleasant Hill, CA, United States of America

James R Manning

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Farmington, CT (US) (2016)
  • Pleasant Hill, CA (US) (2016 - 2024)
  • Emeryville, CA (US) (2023 - 2024)

Company Filing History:

goldMedal13 out of 3,923 
 
Novartis Ag
 patents
silverMedal1 out of 1,970 
 
Amgen Inc.
 patents
where one patent can have more than one assignee

Years Active: 2016-2025

Loading Chart...
Loading Chart...
15 patents (USPTO):
1. 12252482 - Pyrazolopyridine derivatives and uses thereof (2025-03-18),
2. 12172984 - Pyrazolopyridine derivatives and uses thereof (2024-12-24),
3. 12071441 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza (2024-08-27),
4. 11912715 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections (2024-02-27),
5. 11787785 - Pyrazolopyridine derivatives and uses thereof (2023-10-17),
6. 11629149 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza (2023-04-18),
7. 11453677 - Tricyclic compounds useful to treat orthomyxovirus infections (2022-09-27),
8. 11098051 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections (2021-08-24),
9. 10858366 - Tricyclic compounds useful to treat orthomyxovirus infections (2020-12-08),
10. 10160764 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections (2018-12-25),
11. 10112931 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH (2018-10-30),
12. 9688672 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH (2017-06-27),
13. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (2017-01-24),
14. 9434719 - 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH (2016-09-06),
15. D747086 - Pad for soccer sock (2016-01-12),

Title: The Innovative Contributions of James R. Manning

Introduction

James R. Manning is a prominent inventor based in Pleasant Hill, CA, known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, Manning has made remarkable strides in developing compounds that address critical health issues.

Latest Patents

Among his latest patents are the Pyrazolopyridine derivatives and their uses. These compounds are designed to reduce the expression levels of Widely Interspaced Zinc Finger Motifs (WIZ) and induce fetal hemoglobin (HbF) expression. This innovation holds promise for treating inherited blood disorders, including sickle cell disease and beta-thalassemia.

Career Highlights

Manning has had a distinguished career, working with leading companies in the pharmaceutical industry, including Novartis AG and Amgen Inc. His work has focused on developing therapeutic solutions that can significantly improve patient outcomes.

Collaborations

Throughout his career, Manning has collaborated with notable professionals in the field, including Rama Jain and Qian Zhao. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

James R. Manning's innovative work in pharmaceuticals, particularly in the development of Pyrazolopyridine derivatives, showcases his commitment to addressing serious health challenges. His contributions continue to impact the field positively, paving the way for future advancements in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…